Literature DB >> 22150916

Roles of gender, obesity, and lifestyle-related diseases in alcoholic liver disease: Obesity does not influence the severity of alcoholic liver disease.

Makiko Taniai1, Etsuko Hashimoto, Katsutoshi Tokushige, Kazuhisa Kodama, Tomomi Kogiso, Nobuyuki Torii, Keiko Shiratori.   

Abstract

AIM: To elucidate gender differences and the influence of obesity and/or metabolic syndrome-related fatty liver on alcoholic liver disease (ALD), we analyzed characteristic features of ALD.
METHODS: We investigated 266 ALD patients (224 males and 42 females) without hepatocellular carcinoma stratified by gender and the presence of cirrhosis. Male and female patients matched for age and total ethanol intake were also analyzed. A diagnosis of ALD was based on alcohol intake (>70 g daily for more than 5 years), clinical features, and exclusion of other liver diseases. The prevalence of obesity, lifestyle-related diseases, and psychological disorders were assessed.
RESULTS: The prevalence of psychological disorders showed a significant gender difference among all ALD patients (12% in males versus 43% in females, P < 0.001), as well as in patients matched for age and total ethanol intake. There were 156 cirrhotic patients. Absence of dyslipidemia, presence of diabetes, and high total ethanol intake were selected as independent predictors of cirrhosis in males by multivariate analysis after excluding laboratory data of liver function tests. The prevalence of obesity was significantly lower in cirrhotic male patients than in non-cirrhotic male patients (34% vs. 20%, P = 0.023). Among females, there were no significant predictors of cirrhosis on multivariate analysis after eliminating liver function tests. The prevalence of obesity and diabetes was similar in non-cirrhotic and cirrhotic female patients. The prevalence of psychological disorders was 47% in cirrhotic females with ALD.
CONCLUSIONS: Obesity was not common in cirrhotic ALD. Psychological disorders seem to be important for female ALD.
© 2011 The Japan Society of Hepatology.

Entities:  

Year:  2011        PMID: 22150916     DOI: 10.1111/j.1872-034X.2011.00935.x

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  6 in total

Review 1.  Therapy for alcoholic liver disease.

Authors:  Maryconi M Jaurigue; Mitchell S Cappell
Journal:  World J Gastroenterol       Date:  2014-03-07       Impact factor: 5.742

2.  Bariatric surgery and the risk of alcohol-related cirrhosis and alcohol misuse.

Authors:  Jessica L Mellinger; Kerby Shedden; G Scott Winder; Anne C Fernandez; Brian P Lee; Jennifer Waljee; Robert Fontana; Michael L Volk; Frederic C Blow; Anna S F Lok
Journal:  Liver Int       Date:  2021-02-20       Impact factor: 5.828

3.  Influence of light alcohol consumption on lifestyle-related diseases: a predictor of fatty liver with liver enzyme elevation in Japanese females with metabolic syndrome.

Authors:  Masahiro Sogabe; Toshiya Okahisa; Tadahiko Nakagawa; Hiroshi Fukuno; Masahiko Nakasono; Tetsu Tomonari; Takahiro Tanaka; Hironori Tanaka; Tatsuya Taniguchi; Naoki Muguruma; Tetsuji Takayama
Journal:  BMC Gastroenterol       Date:  2016-02-18       Impact factor: 3.067

4.  The differing influence of several factors on the development of fatty liver with elevation of liver enzymes between genders with metabolic syndrome: A cross-sectional study.

Authors:  Masahiro Sogabe; Toshiya Okahisa; Masahiko Nakasono; Hiroshi Fukuno; Yoshihiko Miyamoto; Yasuyuki Okada; Jun Okazaki; Jinsei Miyoshi; Tetsu Tomonari; Tatsuya Taniguchi; Takahiro Goji; Shinji Kitamura; Hiroshi Miyamoto; Naoki Muguruma; Tetsuji Takayama
Journal:  PLoS One       Date:  2017-06-02       Impact factor: 3.240

Review 5.  Alcohol misuse in patients with alcohol-related liver disease: How can we do better? A narrative review of the literature.

Authors:  Jane Horrell; Lynne Callaghan; Ashwin Dhanda
Journal:  Alcohol Clin Exp Res       Date:  2022-07-08       Impact factor: 3.928

6.  Comparison of the role of alcohol consumption and qualitative abdominal fat on NAFLD and MAFLD in males and females.

Authors:  Masahiro Sogabe; Toshiya Okahisa; Takeshi Kurihara; Miwako Kagawa; Hiroyuki Ueda; Tomoyuki Kawaguchi; Akira Fukuya; Kaizo Kagemoto; Hironori Tanaka; Yoshifumi Kida; Tetsu Tomonari; Tatsuya Taniguchi; Koichi Okamoto; Hiroshi Miyamoto; Yasushi Sato; Masahiko Nakasono; Tetsuji Takayama
Journal:  Sci Rep       Date:  2022-09-26       Impact factor: 4.996

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.